## ZETA: Zeta Global Holdings Corp. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 3.0% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: declining volume (56% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($17.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Did Zeta’s Small Equity Raise and Higher 2025–26 Outlook Just Shift ZETA’s Investment Narrative?**
- Source: Simply Wall Street | 20251207T190106 | Bullish | Relevance: 98%
-  Zeta Global Holdings Corp. recently completed a small equity offering and simultaneously raised its revenue guidance for late 2025 and 2026, incorporating the Marigold enterprise software business. This updated outlook, including the contribution from Marigold, is expected to influence Zeta's investment narrative, particularly concerning its AI strategy and path to profitability. While the capital raise was minor, the new guidance highlights management's confidence in future growth despite ongoing competition and profitability challenges.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Morgan Stanley | $23 | $21 | +10% |
| 2025-11-26 | DA Davidson | $29 | $27 | +7% |
| 2025-11-25 | DA Davidson | $27 | $27 | 0% |
| 2025-11-25 | B. Riley Securi | $30 | $29 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Morgan Stanley | main | Equal-Weight |
| 2025-11-26 | DA Davidson | main | Buy |
| 2025-11-25 | DA Davidson | main | Buy |
| 2025-11-25 | B. Riley Securi | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.02M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (-11.4%)
- Blackrock Inc.: 7.8% (-8.8%)
- Contour Asset Manage: 4.1% (+85.2%)
- Greenvale Capital, L: 3.3% (+4.3%)
- Disciplined Growth I: 2.8% (+100.0%)

### Key Risks

1. Elevated short interest (10.1%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +7%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +7.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.94 indicates undervaluation relative to growth. Forward P/E 19.4x attractive for 47% earnings growth. Balance sheet: strong liquidity (3.0x). Revenue growth strong at 34% YoY. Analyst sentiment positive (4 raises, avg +7%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.7B |
| Beta | 1.28 |
| 52W Range | $10.69 - $26.60 |
| Short Interest | 10.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.94 |
| Forward P/E | 19.4 |
| Current P/E | 28.5 |
| YoY Growth | 47.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.8% to 3.0% (+7.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.0pp (needs >4.0% for momentum thesis). MRS_5 at 3.0% confirms short-term momentum alignment. AM_20 at 5.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. Volume at 56% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.05% (CS: 76) | Neutral |
| RSI_14 | 56.6 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.173x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $19.18
- **Stop Loss:** $17.16 (10.5% risk)
- **Target:** $21.20 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 594
- **Position Value:** $11,392.92
- **Portfolio %:** 11.39%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-25 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.18 | $0.27 | +47.2% |
| 2025Q2 | $0.12 | $0.14 | +12.8% |
| 2025Q1 | $0.11 | $0.11 | -1.6% |
| 2024Q4 | $0.22 | $0.25 | +11.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*